Patents by Inventor Kyosuke YAMANISHI

Kyosuke YAMANISHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody
    Patent number: 11219672
    Abstract: A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: January 11, 2022
    Assignees: Medical Research and Development Corporation, Foundation for Biomedical Research and Innovation
    Inventors: Haruki Okamura, Kyosuke Yamanishi, Wen Li
  • THERAPEUTIC AGENT FOR CANCER WHICH COMPRISES COMBINATION OF IL-18 AND MOLECULE-TARGETING ANTIBODY
    Publication number: 20170224791
    Abstract: A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.
    Type: Application
    Filed: August 7, 2015
    Publication date: August 10, 2017
    Inventors: Haruki OKAMURA, Kyosuke YAMANISHI, Wen LI